Candriam Equities L Oncology, I - Capitalisation
WKN A2PAFA | ISIN LU1864482358 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | IE000G3N3NE7 | Janus Henderson Global Life Sciences Fund G2 EUR | +38,37 % | +15,40 % | 2,33 |
|
| 2 | IE00B613WX69 | Janus Henderson Global Life Sciences Fund Z2 USD | +38,23 % | +15,73 % | 2,27 |
|
| 3 | IE00BRJG6X20 | Janus Henderson Global Life Sciences Fund I2 EUR | +37,17 % | +15,35 % | 2,25 |
|
| 4 | LU1864482358 | Candriam Equities L Oncology, I - Capitalisation | +39,93 % | +16,69 % | 2,24 |
|
| 5 | IE00BNGJL640 | Premium Selection UCITS ICAV - Polar Capital Future Healthcare K acc USD | +34,88 % | +14,54 % | 2,22 |
|
| 347 | LU0969575561 | Variopartner SICAV - MIV Global Medtech Fund P3 USD | -14,68 % | +17,02 % | -1,01 |
|
| 348 | LU0329631708 | Variopartner SICAV - MIV Global Medtech Fund I2 EUR | -14,56 % | +16,82 % | -1,02 |
|
| 349 | LU1769944874 | Variopartner SICAV - MIV Global Medtech Fund N2 EUR | -14,73 % | +16,82 % | -1,03 |
|
| 350 | LU0580237955 | Bellevue Funds (Lux) - Bellevue Medtech & Services HB CHF - Accumulating | -14,44 % | +16,25 % | -1,05 |
|
| 351 | LU0329630130 | Variopartner SICAV - MIV Global Medtech Fund P2 EUR | -15,07 % | +16,82 % | -1,05 |
|